The low-density lipoprotein (LDL) receptor (LDL-R) family members (LDL-R, LRP, megalin, VLDL-R, apoER2) bind several extra-cellular structurally dissimilar ligands and internalize them for degradation by lysosomes by a process called receptor-mediated endocytosis. The receptor-mediated endocytosis involves immobilization of circulating ligands onto the cell-surface followed by their internalization and degradation. All the receptors can perform both of these functions. However, in the majority of the cases, other proteins immobilize ligands on to the cell-surface and subsequent internalization is mediated by these receptors. The LDL-R and LRP play important roles in plasma cholesterol homeostasis and fetal development. Megalin is an antigenic determinant for Heymann nephritis in rats and may be important for reabsorption of various molecules by the kidney. VLDL-R homologue in chicken is essential for female fertility. This receptor and apoER2 are critical for the proper development of the brain in mice. The members of the LDL-R gene family contain several complement-type and EGF precursor-like repeats, and single transmembrane and cytoplasmic domain. Cysteine-rich complement-type repeats containing DxSDE sequences at the C-termini constitute ligand-binding domains. In contrast to the ligand binding domains, receptor-binding domains in different ligands do not share sequence homology. It has been proposed that positive electrostatic surface potentials, not the primary sequences, in different ligands constitute receptor-binding domains. The EGF precursor homology repeats in receptors are important for the dissociation of ligands from receptors in endocytic vesicles. The transmembrane domain is necessary for anchoring to membranes and the cytoplasmic domain is required for their targeting to coated pits and subsequent internalization. The receptor-mediated endocytosis involves recognition of the NPXY motif by clathrin. Recently, this motif has also been implicated in signaling pathways that are crucial in brain development. The signaling process involves the recognition of the NPXY motif by Disabled-1 protein and possibly other proteins involved in intracellular signaling cascade. The LDL-R gene family has provided important insights into the mechanisms of ligand catabolism and may serve as new targets for the treatment of different cardiovascular and neuronal disorders. In the future, their
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INTRODUCTION
The LDL-R gene family consists of transmembrane receptors that reside on the cell-surface and require Ca +2 for ligand binding (table 1) . All the members recognize two structurally dissimilar proteins; receptor associated protein (RAP) and apolipoprotein E (apo E). These receptors share several structural motifs and functional properties and interact with a diverse group of ligands. In contrast to the signaling receptors that contain large intracellular domains, all the members of the family are trans-membrane glycoproteins that contain large extracellular and comparatively shorter intracellular domains, and lack enzymatic activities. The receptors bring various ligands from the extracellular environment into the cell for degradation and thus potentially control cellular phenotypes by modulating extracellular levels of various proteases, protease inhibitors, and growth factors. The knowledge concerning structural and functional domains, regulation of expression in various tissues, and diseases that arise due to receptor dysfunction has been discussed and reviewed (1) . Here, I will summarize current understanding about structural motifs, biochemical features, endocytic properties, and their role in the signaling during brain development.
STRUCTURAL MOTIFS AND FUNCTION
Different receptors were placed in this family because of the sequence homologies in the four characteristic structural and functional motifs: complementtype cysteine-rich repeats, EGF precursor-like repeats, membrane-spanning region, and intracellular domain containing at least one internalization signal sequence (FDNPXY). Each complement-type repeat consists of ≈ 40 amino acids and contains six cysteine residues and one DxSDE sequence at the C-terminal end. Different receptors contain different numbers of these repeats (table 2) , and a single repeat or several repeats constitute a ligand-binding domain. All the cysteine residues within a repeat are disulfide linked forming stable and compact, functionally independent motifs. It has been speculated that differential clustering of these repeats within a domain may be responsible for the specificity toward different ligands (1) . The EGF precursor homology domains consist of cysteinerich growth factor and YWTD repeats. The negatively charged residues (DxSDE) found in ligand binding domains are not present in the cysteine-rich EGF precursor domain. The growth hormone repeats of ≈ 50 amino acids are usually separated by a group of five YWTD repeats. The EGF precursor homology domains are necessary for the dissociation of ligands from the receptor in endosomes (2) (3) (4) . In addition to these two cysteine-rich regions, all the members contain a single transmembrane domain of hydrophobic amino acid residues that help them anchor into membranes. The cytoplasmic domains contain at least one FDNPXY sequence necessary for the targeting of receptors to coated pits and subsequent internalization. In the brain, this sequence recruits adapter proteins involved in signal transduction.
LDL receptor
The LDL-R is a cell-surface, transmembrane glycoprotein of 839 amino acids. It controls plasma cholesterol by mediating uptake and catabolism of apoB100-and apoE-containing lipoproteins from plasma (table 3) . The N-terminal ligand-binding domain consists of seven cysteine-rich, complement-type repeats (table 2) . It also contains three EGF precursor homology domains and one O-linked glycosylated domain. The membranespanning region is rich in hydrophobic amino acid residues and is necessary for membrane anchoring. This region is not well conserved within different species. The cytoplasmic domain is highly conserved and contains an internalization signal. Different structural and functional domains of the receptors are derived from different exons. Exons 2-6, 7-14, 15, and 16-17 code for complement-type ligand binding domain, EGF precursor homology domain, O-linked glycosylation domain, and membrane spanning and cytoplasmic domains, respectively. Deletion of individual repeats and site-directed mutagenesis causing amino acid substitutions showed that complement-type repeats 3-7 and EGF precursor repeat A were required for the optimal binding of apoB, whereas only complementtype repeat 5 was crucial for apoE binding (5, 6) . The three-dimensional structures of recombinant complement repeat 1 and 2 have been solved by NMR spectroscopy and complement repeat 5 by X-ray crystallography. These studies indicate that these repeats form a beta-hairpin structure exposing highly conserved acidic residues on one side of the molecule (7, 8) . The X-ray structural studies have indicated that conserved acidic residues were not exposed to the surface but were involved in Ca +2 binding and raised doubts about the mechanism of interactions between the receptors and various ligands (8) . Nonetheless, the majority of biochemical and molecular evidence suggests that various repeats containing a cluster of negative charges, alone or in combination, contribute to specific, high affinity binding of apoE and apoB (for reviews, (2-4).
The major function of the LDL-R is to control plasma cholesterol levels. Mutations in the LDL-R gene cause familial hypercholesterolemia and it is the most common monogenic human disease with a heterozygous frequency of 1 in 500. The homozygotes, expressing nonfunctional receptors, have dramatically increased plasma cholesterol levels, and develop cutaneous 
LDL receptor-related protein (LRP)
LRP was the second member of the family identified by Herz et al. (9) . It is synthesized as a single polypeptide of 4525 amino acids and is cleaved in the Golgi compartment by furin to produce two subunits of 515-and 85-kDa that remain non-covalently attached to each other (10, 11) . The larger subunit contains 31 acidic, cysteine-rich complement-type repeats clustered as 2, 8, 10 and 11 repeats in four domains (table 2) . This subunit also contains 21 cysteine-rich EGF precursor-like repeats and O-linked glycosylation sites. The 85-kDa subunit is made up of a trans-membrane and a cytoplasmic domain containing two copies of the NPXY sequence that is important for endocytosis. LRP is involved in the metabolism of many structurally diverse proteins, proteinases, protein-lipid complexes, and proteinaseinhibitor complexes (table 3) . Several experimental approaches have been used to identify regions in LRP that bind to various ligands (for a detailed discussion and references see (1) ). These studies showed that domain 1 does not bind ligands. Domain 2 binds almost all the ligands such as alpha 2 -M * , uPA:PAI-1, lipoprotein lipase, tPA:PAI-1, apoE, factor VIII, and RAP. Within this domain sub-domains C3-C7 may be important for ligand binding (12) . Recently, it has been shown that domain 4 shares ligand-binding properties with domain 2 (12) . Thus, different cyteine-rich complement-type repeats act independently and bind different ligands simultaneously and that a complete receptor is unnecessary for ligand binding.
In contrast to the LDL-R, mutations in LRP causing human disorders have not been described. It may indicate that it is essential for fetal development and that mutations may be lethal. In mice, LRP is required for the development of the fetus since deletion of the LRP gene results in the death of fetuses around day 10 (13). The physiological and biochemical reasons for early fetal death are not known. In addition to an important role in development, evidence suggests that LRP and a number of its ligands contribute to the development of Alzheimer's disease. LRP binds and internalizes proteins genetically associated with Alzheimer? s disease, such as certain secreted forms of amyloid precursor protein, apoE (14) and the alpha 2 -macroglobulin (15, 16) . Recent genetic evidence suggests that a polymorphism within LRP itself may be associated with the expression of late-onset Alzheimer? s disease. However, molecular basis for the association between LRP polymorphism and Alzheimer? s disease is not known.
Megalin
It is a single polypeptide of 4,660 amino acids that is primarily expressed in the absorptive epithelial cells (17) . The extracellular domain contains 36 cysteine-rich ligand binding and 16 EGF-precursor homology domains containing 40 YWTD repeats in (table 2) . There are four ligand binding domains consisting of 7, 8, 10 and 11 complement-type repeats in the molecule that recognize several ligands (table 2) . The intracellular domain contains two internalization signal sequences. In addition, it contains Src-homology binding regions, casein kinase II sites and protein kinase phosphorylation sites (18) . The cellular expression pattern of the receptor indicates that it plays an important role in the absorption of some molecules by the intestine, re-absorption of proteins and vitamins by the kidney, and transport across the blood-brain barrier (for reviews, (1, (18) (19) (20) (21) ).
Mice lacking megalin die within 2-3 h after birth due to defects in pulmonary inflation and alveolar expansion (22) . These mice develop the holoprosencephalic syndrome (abnormal forebrain development, absence of olfactory apparatus etc.) indicating that megalin may be important in the development of the brain. Heymann nephritis in rats is caused by the formation of subepithelial immune deposits in glomerular basement membrane. It occurs due to the binding of circulating antibodies to two antigens, a cell-surface receptor megalin and an endoplasmic reticulum-resident RAP. Binding of antibodies to these antigenic determinants results in intracellular immune-deposits in the glomerular basement membrane, damage to glomerular capillary wall, and proteinuria (for reviews, (18-21).
VLDL receptor
The VLDL-R is very similar to the LDL-R (23). It contains one extra complement-type repeat than the LDL-R at the N-terminus in the ligand-binding domain (table 2) . Not only the structural motifs but also the gene structures of these two receptors are very similar (24). The different functional motifs in the VLDL-R are encoded by different exons similar to that of the LDL-R. Two variants (126, 127) of the receptor differing in molecular weight due to the presence or absence of the serine/threonine-rich O-linked glycosylation motif have been described (24-26). The presence or absence of this O-linked glycosylation site affects the size of the protein but has no effect on ligand binding properties (26). The tissue expression of the VLDL-R is very different from that of the expression of the LDL-R (table 3) . In contrast to the LDL-R, the majority of the VLDL-R is expressed in extrahepatic tissues, e.g., heart, muscle, and adipose tissue. Thus, the VLDL-R may function in the uptake of triglyceride-rich, apoE-containing lipoproteins in tissues that are active in fatty acid metabolism (for reviews, (1, (27) (28) (29) ).
Disruption of the VLDL-R gene in mice has no significant effect on fertility and lipoprotein catabolism in mice (30). However, it results in modest decrease in the whole body and adipose tissue mass. In contrast, mutations in the chicken homologue of this receptor result in female sterility. Chickens do not lay eggs because of the failure in the deposition of egg yolk proteins. These birds also develop severe hyperlipidemia associated with premature atherosclerosis (31). VLDL-R is a good candidate for hepatic gene therapy to control hyperlipidemias because it is not expressed in the liver and is not expected to be immunogenic. The adenovirusmediated overexpression of VLDL-R in the livers of LDL-R deficient mice resulted in marked decrease in plasma apoE, apoB100, and cholesterol (32,33). Similarly, VLDL-R expression in the livers of apoE deficient mice expressing E2 and apoE-Leiden resulted in decreased plasma cholesterol levels (34). Thus, hepatic expression of this receptor may be useful in controlling hyperlipidemias. The relative abundance ( +++>++>+ ) of different receptor mRNAs. Absence of detection is represented by "_".
Apo E receptor 2 (ER2)
The human apoE receptor 2 (apoER2) contains seven ligand-binding repeats and is mainly found in the brain (35,36). The ligand binding complement-type cysteine-rich repeats are grouped very similar to that observed in the VLDL-R and are different from those observed in the LDL-R. Furthermore, the ER2 is closer to VLDL-R than LDL-R with respect to sequence homology and restricted tissue expression (table 4) . Thus, it may bind several ligands as the VLDL-R (table 3) . The EGF precursor homology with YWTD repeats, O-linked glycosylation motif, membrane anchoring region, and cytoplasmic domain with one internalization signal are similar to those present in the LDL-R and VLDL-R.
Recently, VLDL-R and apoER2 have been shown to play an important role in developmental neurobiology. Reelin is a large extracellular protein produced by the Cajal-Retzius cells in the developing brain. It is produced in specific regions that control neuronal migration and positioning in the cerebral cortex and cerebellum (37). Reelin has recently been shown to bind both the VLDL-R and apoER2 (38,39). This binding results in increased intracellular phosphorylation of Disabled-1 protein in cultured primary neurons (38). Phosphorylated Disabled-1 is known to interact with non-receptor tyrosine kinases of the Abl and Src family. Thus, reelin may signal via VLDL-R and apoER2 to control neuronal migration and positioning during development by recruiting intracellular Disabled-1 to these receptors and initiating a signaling cascade.
LR11
RAP-affinity chromatography and homology cloning resulted in the identification of LR11 or SORLA-1 (40,41). It is a hybrid receptor consisting of a ligandbinding domain of 11 complement-type repeats, 5 YWTD repeats, 1 membrane spanning region, and 1 cytoplasmic domain containing an internalization signal. It lacks EGF precursor homology repeats, but instead contains domains homologous to the vacuolar sorting receptor of yeast and fibronectin type III repeats observed in adhesion molecules. The presence of fibronectin type III repeats indicate that it may play a role in cell-cell interactions especially between neurons (40-43).
Other receptors
Some other related receptors that have been shown to contain ligand binding repeats are LRP3, LRP6, and LRP7 (44-48) . Petersen et al have isolated and characterized a novel receptor that binds to RAP but does not appear to share sequence homology with the LDL-R family members (49). The receptor has been called Sortilin and appears to bind RAP, lipoprotein lipase and neurotensin (49,50).
ENDOCYTIC PROPERTIES OF THE LDL-R GENE FAMILY

Ligands of the LDL-R gene family
Different receptors of the LDL-R gene family recognize several ligands. Similarly, different ligands are recognized by multiple receptors (table 3) . However, each receptor appears to have a unique ligand (table 3) . For example, alpha 2 -macroglobulin only binds to LRP and this binding is inhibited by nickel (51-53). ApoJ may be a specific ligand for megalin. So far, apoB100 has been shown to bind to the LDL-R and megalin only (2,54). Molecular and biochemical bases for these specific interactions are not known.
RAP and apoE are very dissimilar in their amino acid sequences and yet both of these proteins are recognized by all of the family members (tables 1 & 3) . RAP is a chaperone that assists in the proper folding of LRP and prevents premature intracellular binding of ligands to the receptor (55-57). Remarkably, it binds to all the receptors and acts as a potent inhibitor for the binding of all ligands to all the receptors probably because of its small size, compact structure and its ability to bind receptors at multiple sites (58,59). On the other hand, apoE is a secreted protein that acts as a ligand (tables 1 & 3) after associating with lipids or lipoproteins (60). It has a single receptor-binding domain and does not compete very well for the binding of other ligands. There are three apoE alleles that give rise to three different charged isoforms. Only the LDL-R distinguishes between these different isoforms. The binding affinities of the receptor for these isoforms are in the order of apoE4>apoE3>>apoE2 (60). The poor binding of apoE2 to the LDL-R results in type III hyperlipoproteinemia (61). Other receptors in the family do not differentiate between these isoforms and bind all the isoforms.
Most of the ligands recognized by the receptors exist in at least two structural conformations, and only one of these conformations is recognized by the receptors. This is especially true for apoE, alpha 2 -macroglobulin, and serine proteinase inhibitors (serpins). ApoE exists either free or associated with lipoproteins in plasma. The LDL-R family members recognize apoE that is bound to lipids or lipoproteins and do not recognize lipid-free apoE (60). Alpha 2 -macroglobulin is a large plasma proteinase inhibitor that reacts with all major classes of proteinases (for reviews, (62,63)). The native form of alpha 2 -macroglobulin is not recognized by LRP. When native alpha 2 -macroglobulin interacts with different proteinases, these proteinases cleave the ? bait? region in the native alpha 2 -macroglobulin molecule and induce a conformational change that results in the exposure of binding sites recognizable by LRP. Like alpha 2 -macroglobulin, the serpins are substrates for various proteinases and various proteinases cleave an exposed loop region in these proteins. The LDL-R gene family members recognize serpin complexes containing inactive proteinases. PAI-1 differs from the other serpins and exists in four different forms: native or active, latent, cleaved, and the proteinase complexed form. The LDL-R family recognizes PAI-1 complexed to a proteinase, such as the uPA:PAI-1 complex. Thus, the receptor-binding domain in the native ligands is either buried or does not exist. Conformational changes in these ligands help expose a site on the surface of the molecule that is recognized by these receptors and these conformational changes signal for their removal from plasma.
Different ligands that bind to the LDL-R family members do not share significant sequence homology. However, all the ligands bind to heparin and contain basic domains rich in arginine and lysine residues. Several mutagenesis experiments have shown that positively charged basic amino acids are critical for receptor binding. Attempts have been made to derive consensus primary sequences that might constitute receptor-binding domains (1,64). There is very little sequence homology between different receptor-binding domains. Thus, it has been proposed that secondary or tertiary structural motifs rich in positive electrostatic surface potential may constitute a receptor-binding domain in different ligands (1) . Proteins of different primary sequences may fold to expose a similar secondary or tertiary cluster of charges. The clusters of the basic amino acids may contribute to the positive electrostatic potential on the surface of these molecules and these positive potentials can form various contacts with an area of negative electrostatic potential present on the surface of receptor molecules.
Endocytosis of different ligands
Receptors and ligands bind to each other with high affinity. High affinity binding indicates that receptors can recognize ligands present at low concentrations (# 10 (table 1) . In intracellular compartments, ligands dissociate from receptors and ligands are transferred to lysosomes for degradation whereas receptors are recycled back to cellsurface. The process of receptor-mediated endocytosis involves the extraction of ligands from circulation onto the cell-surface and subsequent internalization of receptorligand complexes. LDL-R family members can perform both of these functions. For example, LDL-R extracts LDL from plasma, immobilizes it at least transiently onto cellsurface, and subsequently internalizes it for degradation. Similarly, LRP binds alpha 2 -macroglobulin/proteinase complexes and internalizes them for intracellular degradation. In other instances, family members cooperate with other cell-surface proteins in the endocytic process. In these instances, other cell-surface proteins extract ligands and immobilize them onto the cell-surfaces. This allows further modification of the ligands on the cell-surface. Subsequently, these ligands are delivered to the LDL-R family members for the final internalization and delivery to lysosomes. It is known that remnant lipoproteins bind proteoglycans. The proteoglycan-immobilized remnant lipoproteins are probably further enriched with apoE. The apoE-enriched remnant lipoproteins are then transferred to LRP for internalization and degradation (for reviews, (65)).
An endocytic process originates at specialized regions in the inner surface of the plasma membrane called coated pits. The assembly of coated pits occurs by the binding of dephosphorylated AP-2 (adaptor protein) complexes to the plasma membrane, recruitment of clathrin from the cytosol, and formation of clathrin-coated vesicles. Different receptors from other regions of the plasma membrane are recruited to the coated region for internalization. The recruitment of LDL-R family members involves the binding of the FDNPXY motifs with the terminal domains of the clathrin heavy chain (66) . The coated pits are pinched off from the membrane as coated vesicles in an energy-dependent process mediated by dynamin. The coated vesicles undergo rapid uncoating in the cytoplasm and contents from these uncoated vesicles are delivered to endosomes by a docking and fusing mechanism involving v-and t-SNAREs. In the endosomes, slightly acidic pH facilitates the dissociation of ligands from receptors, and receptors and ligands are separated into two different compartments. In this process, lumenal contents accumulate in vesicular regions and receptors accumulate in the tubular extensions of endosomes. The tubular extensions with receptors are recycled to the plasma membrane and vesicles fuse with late endosomes or prelysosomes containing enzymatically active lysosomal hydrolases that degrade the ligands (for reviews, (67-71)).
SIGNALING BY THE LDL-R GENE FAMILY IN BRAIN
As discussed above an important function of the LDL-R gene family is to bring extracellular ligands into cells for degradation. The NPXY motif present in the intracellular domains of these receptors is critical for the endocytic function. The NPXY motif is also found in other receptors that are not involved in endocytosis but are involved in signaling. For example, epidermal growth factor receptor contains NPXY sequence in which the tyrosine residue is phosphorylated after the receptor binds to its ligand. The phosphorylated NPXY motif then binds to protein interacting domains present in Shc protein. Shc is an adapter protein that interacts with ras signaling pathway. The mammalian Disabled-1 is a cytoplasmic protein that contains one protein interacting domain and acts as an adapter protein in phosphorylation dependent intracellular signal transduction (73) . The protein interacting domain of Disabled-1 interacts with NPXY motif in the LDL-R gene family (72) . Disbaled-1 is known to undergo phosphorylation and several proteins that contain SH2 domains bind to the phosphorylated Disabled-1. This binding plays an important role in the amplification of the signals. Mutations in Disabled-1 result in the disruption of the migration of neurons during development in scrambler mice (73) . The extracellular signal for the activation of Disabled-1 appears to be the binding of reelin to cell surface receptors (37). Reelin is a large extracellular matrix protein synthesized and secreted by Cajal-Retzius cells in the forebrain and by granule neurons in the cerebellum (37,73). Autosomal recessive mutations in reelin in reeler mice result in widespread disruption of laminar structure throughout the brain. The phenoype is very similar to that observed in scrambler mice with defects in Disabled-1. Surprisingly, similar phenotype is also observed in mice that lack functional VLDL-R and apoER2 receptors (74) . Furthermore, reelin has been shown to bind VLDL-R and apoER2 (38,75). It is conceivable that reelin binds to the extracellular ligand binding domains of the VLDL-R and apoER2 receptors and this binding result in the recruitment of Disabled-1 to the NPXY motifs in the intracellular domains of these receptors. The NPXYanchored Disbaled-1 is then phosphorylated and interacts with other proteins that contain SH2 domains. These interactions may amplify signaling pathways that are crucial for the proper migration and growth of neurons. Thus, reelin, Disbaled-1, VLDL-R and apoER2 may form an integrated signaling cascade that is crucial for the proper migration and layering of the neurons during brain development.
CONCLUDING REMARKS
Significant information concerning the structural and functional motifs in different receptors of the LDL-R family has been obtained. Since, these receptors recognize structurally dissimilar ligands they play significant and very diverse physiological processes such as fetal development, brain development, cholesterol homeostasis, cellular migration, immune response, and protease clearance from the plasma. Furthermore, they have been implicated in atherosclerosis and neurodegenerative diseases. Studies with these receptors have helped understand receptor-ligand binding and endocytic processes. New studies are providing fascinating new information about the role of these receptors in signaling and fetal development. It is anticipated that the knowledge may be useful in the control of atherosclerosis and neurologic disorders.
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